Curis (CRIS) Prepaid Assets (2010 - 2026)
Curis' (CRIS) quarterly Prepaid Assets came in at $1.6 million in Q1 2026, down 27.28% YoY from $2.2 million in Q1 2025, and down 13.16% on a QoQ basis from $1.9 million in Q4 2025.
Curis (CRIS) Prepaid Assets (2010 - 2026) Analysis & Trends
Curis (CRIS) has 17 years of Prepaid Assets data on file, last reported at $1.6 million in Q1 2026.
- Quarterly Prepaid Assets fell 27.28% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (down 27.28% YoY) and the FY2025 annual result came in at $1.9 million, down 38.99% from the prior year.
- Prepaid Assets slipped to $1.6 million in Q1 2026, from $1.9 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $4.1 million in Q3 2022 to a low of $1.5 million in Q2 2025.
- A 5-year average of $2.7 million and a median of $3.0 million in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets soared 140.11% — and 2025, when it tumbled 57.74%.
- Tracing CRIS's Prepaid Assets over 5 years: stood at $3.5 million in 2022, then slumped by 49.45% to $1.8 million in 2023, then surged by 70.73% to $3.0 million in 2024, then tumbled by 38.99% to $1.9 million in 2025, then decreased by 13.16% to $1.6 million in 2026.
- The last three Prepaid Assets figures came in at $1.6 million (Q1 2026), $1.9 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Curis | 3.27 Mn | -2.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.61 Mn |
| Dec 31, 2025 | 1.85 Mn |
| Sep 30, 2025 | 1.61 Mn |
| Jun 30, 2025 | 1.53 Mn |
| Mar 31, 2025 | 2.21 Mn |
| Dec 31, 2024 | 3.04 Mn |
| Sep 30, 2024 | 3.11 Mn |
| Jun 30, 2024 | 3.62 Mn |
| Mar 31, 2024 | 3.19 Mn |
| Dec 31, 2023 | 1.78 Mn |
| Sep 30, 2023 | 2.08 Mn |
| Jun 30, 2023 | 1.98 Mn |
| Mar 31, 2023 | 3.94 Mn |
| Dec 31, 2022 | 3.52 Mn |
| Sep 30, 2022 | 4.14 Mn |
| Jun 30, 2022 | 3.80 Mn |
| Mar 31, 2022 | 3.43 Mn |
| Dec 31, 2021 | 3.27 Mn |
| Sep 30, 2021 | 3.09 Mn |
| Jun 30, 2021 | 1.58 Mn |